Denmark-based pharmaceutical company Novo Nordisk will no longer use live animals in biological batch testing.
The company has confirmed the last test involving the use of animals occurred on 28 November, used to test the company’s haemophilia product recombinant Factor VII.
Novo Nordisk chief science officer Mads Krogsgaard Thomsen lauded the achievement, adding: "We have been working for more than a decade, in close collaboration with regulatory authorities around the world, to eliminate obsolete tests or develop and certify new laboratory assays that can be used instead of animals."
Having marked the end of the company’s animal testing, Novo Nordisk will now use cells from hamster and other animals in testing production batches, allowing more precision and reliability.
Following a growing number of employees questioning the validity of animal testing procedures, Novo Nordisk established a task force tasked with removing redundant product-control tests in live animals.
The number of animals used at Novo Nordisk has fallen from more than 13,000 a year in the 1990s to just 772 in 2010.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData
Caption: Animals have been used in the laboratory testing of pharmaceutical products, but will no longer be used by Novo Nordisk.